Status: current, Defined. Date: 31-Jul 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3026631000168113 | Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3047371000168118 | Anzemet (dolasetron mesilate monohydrate 12.5 mg / 0.625 mL) injection, 0.625 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3087601000168113 | Anzemet (dolasetron mesylate monohydrate 12.5 mg / 0.625 mL) injection, 0.625 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | has Australian BoSS | dolasetron mesilate monohydrate | true | Inferred relationship | Some | 2086457811 | |
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | Is a | Anzemet | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | Is a | dolasetron mesilate monohydrate 12.5 mg/0.625 mL injection, vial | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | has intended active ingredient | dolasetron | true | Inferred relationship | Some | 2086457811 | |
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | has unit of use | vial | true | Inferred relationship | Some | 2086457812 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | has TPUU | True | Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | Inferred relationship | Some | 1 |
| Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | has TPUU | True | Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR